US SEC Trading Suspension Halt Orders — October 09, 2026

09-10-2026

Streamex Corp. (NASDAQ: STEX) received a Nasdaq Listing Qualifications notice on October 7, 2026, stating it is not in compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), based on 30 consecutive business days of closing bid prices from August 25, 2026 through October 6, 2026. The Company has a 180-calendar-day compliance period until April 5, 2027 to regain compliance, and the notice has no immediate effect on the listing or trading of its common stock.

• · Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period, with a deadline of April 5, 2027
• · If not compliant by April 5, 2027, the Company may qualify for a second 180-day period only if it meets the publicly held shares market value requirement and other initial listing standards (excluding bid price) and gives written notice of intent to cure, potentially including a reverse split
• · A reverse stock split, if used, must be completed no later than ten business days before April 5, 2027
• · Failure to cure may lead to a delisting notice, which can be appealed to a Nasdaq Hearings Panel
• · The filing includes forward-looking statements citing market conditions and macroeconomic factors affecting digital asset markets, suggesting the Company's business is tied to digital assets

09-10-2026

Accendra Health, Inc. (NYSE: ACH), the entity formerly known as Owens & Minor Inc. (OMI) as indicated by the EDGAR header, received a notice from the NYSE on October 6, 2026 for non-compliance with Section 802.01C because its average closing price fell below $1.00 per share over 30 consecutive trading days. The notice has no immediate impact on the listing, and the company has six months to regain compliance, which it intends to pursue. The company will notify the NYSE of its intent to cure within 10 business days.

• · Notice was received October 6, 2026 under NYSE Listed Company Manual Section 802.01C.
• · A press release was issued October 9, 2026 and furnished as Exhibit 99.1 under Item 7.01 (not deemed filed).
• · The notice states it does not affect business operations or SEC reporting obligations.
• · Cure requires a closing price of at least $1.00 on the last trading day of a month, with a 30-day average also at least $1.00.

09-10-2026

Better Home & Finance Holding Company notified Nasdaq on October 5, 2026 that, following board resignations and removals disclosed in 8-Ks filed October 2 and October 6, 2026, it no longer complies with several Nasdaq corporate governance rules, including board independence, audit committee, compensation committee, and independent director nomination requirements. Nasdaq's October 8, 2026 notice gives the company 45 calendar days to submit a compliance plan, and the notice has no immediate effect on the listing of its Class A common stock or warrants, though failure to regain compliance could lead to delisting.

• · Nasdaq cited non-compliance with Listing Rule 5605(b)(1) (majority independent board), 5605(c)(2) (audit committee), 5605(d) (compensation committee), and 5605(e)(1) (independent director nominations)
• · The company is an emerging growth company
• · The company states it intends to submit a compliance plan within the 45-day period but gives no assurance Nasdaq will accept it

09-10-2026

Alaunos Therapeutics (Nasdaq: TCRT) received a written notice from Nasdaq's Listing Qualifications Staff on October 5, 2026 that its securities are subject to delisting for failing to maintain the minimum $2.5M stockholders' equity required under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market. The company, which received the initial deficiency notice on April 9, 2026 and submitted a compliance plan, intends to request a hearing before the Nasdaq Hearings Panel, which will stay any suspension or delisting action until the hearing and any Panel-granted extension expire. The company is also exploring strategic alternatives with a financial advisor, but management states there is no assurance the Panel will grant continued listing or that any transaction will be identified, completed, or restore compliance.

• · Initial Nasdaq deficiency notice received April 9, 2026; company timely submitted a compliance plan
• · Delisting notice received October 5, 2026; company plans to timely request a Nasdaq Hearings Panel hearing, which stays further suspension or delisting action
• · Company is working with a financial advisor on one or more potential transactions it believes would restore compliance with all Nasdaq continued listing criteria
• · Any potential transaction remains subject to negotiations, due diligence, definitive agreements, required approvals, and closing conditions

09-10-2026

IT Tech Packaging, Inc. (NYSE American: ITP) disclosed it is not in compliance with NYSE American continued listing standards because it failed to timely file its Form 10-K for FY2025 and Forms 10-Q for the quarters ended March 31, 2026 and June 30, 2026. On October 7, 2026, NYSE Regulation accepted the company's October 1, 2026 extension request and granted a plan period through April 15, 2027 to complete the delayed filings; the stock continues to trade on NYSE American during the plan period but carries a late filer (.LF) indicator. The company says it expects to file on or before the deadline but offers no assurance it will do so.

• · Delisting proceedings will be initiated if the company does not make progress consistent with the plan or does not complete all delayed filings by April 15, 2027; the company may appeal a staff delisting determination under Section 1010 and Part 12 of the Company Guide.
• · The extension request was submitted October 1, 2026 and accepted October 7, 2026, and the company issued a press release on October 9, 2026 as required by Sections 402 and 1009(e) of the Company Guide.
• · Filing references Sections 134 and 1101 of the NYSE American Company Guide as the basis for non-compliance.